Open access
Open access
Powered by Google Translator Translator

Breast Surgery

M-A | Margin status and survival outcomes after breast cancer conservation surgery.

23 Sep, 2022 | 13:09h | UTC

Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis – The BMJ

Commentary from the authors: Width of excision margins after breast conserving surgery for invasive breast cancer and distant recurrence and survival – The BMJ

News Release: Experts call for adequate tumour free margins in breast cancer surgery – BMJ Newsroom

 


RCT | Multiple doses of prophylactic intravenous antibiotics are no better than a single dose in implant-based breast reconstruction.

19 Sep, 2022 | 12:48h | UTC

Effectiveness of Single vs Multiple Doses of Prophylactic Intravenous Antibiotics in Implant-Based Breast Reconstruction: A Randomized Clinical Trial – JAMA Network Open

 

Commentary on Twitter

 


Cohort Study | Fertility preservation procedures appear to be safe at the time of breast cancer diagnosis.

7 Sep, 2022 | 12:31h | UTC

Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis – JAMA Oncology

News Release: Fertility preservation measures do not appear to increase the risk of breast cancer recurrence – Karolinska Institutet

Commentary: Fertility Preservation Measures Do Not Appear to Increase the Risk of Breast Cancer Recurrence – The ASCO Post

 


Cohort Study | 5-year follow-up results suggest it is safe to de-escalate radiotherapy after primary chemotherapy in cT1–2N1 breast cancer.

31 Aug, 2022 | 11:45h | UTC

De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study – The Lancet Oncology (link to abstract – $ for full-text)

Commentary: Treatment De-Escalation With Locoregional Radiotherapy Appears Safe in cT1-2N1 Breast Cancer – Cancer Network

 

Commentary on Twitter

 


Spindle cell lesions of the breast: a diagnostic algorithm.

23 Aug, 2022 | 12:51h | UTC

Spindle Cell Lesions of the Breast: A Diagnostic Algorithm – Archives of Pathology & Laboratory Medicine

 


RCT | Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast.

9 Aug, 2022 | 12:46h | UTC

Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study – The Lancet (link to abstract – $ for full-text)

 


Cohort Study | Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer.

9 Aug, 2022 | 12:20h | UTC

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer – npj Breast Cancer

 

Commentary on Twitter

 


RCT | Partial breast irradiation vs. whole breast irradiation for early breast cancer.

8 Aug, 2022 | 11:36h | UTC

Partial Breast Irradiation Versus Whole Breast Irradiation for Early Breast Cancer Patients in a Randomized Phase III Trial: The Danish Breast Cancer Group Partial Breast Irradiation Trial – Journal of Clinical Oncology (link to abstract – $ for full-text)

 


M-A | Breast cancer recurrence after immediate and delayed postmastectomy breast reconstruction.

28 Jul, 2022 | 13:05h | UTC

Breast cancer recurrence after immediate and delayed postmastectomy breast reconstruction—A systematic review and meta-analysis – Cancer

 


NCCN Updated Guideline: Breast cancer.

20 Jun, 2022 | 01:24h | UTC

Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

 


Cohort Study: Association of screening with digital breast tomosynthesis vs. digital mammography with risk of interval invasive and advanced breast cancer.

17 Jun, 2022 | 11:09h | UTC

Association of Screening With Digital Breast Tomosynthesis vs Digital Mammography With Risk of Interval Invasive and Advanced Breast Cancer – JAMA (free for a limited period)

Editorial: Digital Breast Tomosynthesis and Detection of Interval Invasive and Advanced Breast Cancers – JAMA (free for a limited period)

News Release: 3-D Mammography Technique Benefits Some Women, Not All – University of California San Francisco

 


Regional lymphadenopathy following COVID-19 vaccination in patients with or suspicious of breast cancer: a quick summary of current key facts and recommendations.

14 Jun, 2022 | 11:07h | UTC

Regional Lymphadenopathy Following COVID-19 Vaccination in Patients with or Suspicious of Breast Cancer: A Quick Summary of Current Key Facts and Recommendations – Korean Journal of Radiology

Related:

2 Case Series and Guidance | Lymphadenopathy in COVID-19 Vaccine Recipients

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI) – Insights into Imaging

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance – The BMJ

Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination – European Radiology

Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care – European Journal of Cancer

 


Circulating tumor DNA and late recurrence in high-risk hormone receptor–positive, human epidermal growth factor receptor 2–negative breast cancer.

13 Jun, 2022 | 07:35h | UTC

Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer – Journal of Clinical Oncology

Editorial: Can a Late Interception by Circulating Tumor DNA Deliver a Win in Estrogen Receptor–Positive Early Breast Cancer?

Commentary: Tumor DNA Assay Portends Metastatic Breast Cancer Recurrence Months in Advance — First evidence for patients in late adjuvant setting, years after initial diagnosis – MedPage Today (free registration required)

 

Commentary on Twitter

 


Cohort Study: Long-term quality of life in patients with breast cancer after breast conservation vs mastectomy and reconstruction.

9 Jun, 2022 | 10:30h | UTC

Long-term Quality of Life in Patients With Breast Cancer After Breast Conservation vs Mastectomy and Reconstruction – JAMA Surgery (link to abstract – $ for full-text)

Commentaries:

Long-Term QOL Examined for Surgical Choices in Breast Cancer – HealthDay

Improved Long-Term Quality-of-Life Measures in Women Undergoing Breast Conservation vs Mastectomy and Reconstruction for Early Breast Cancer – The ASCO Post

 

Commentary on Twitter

 


Phase 2 RCT: Efficacy of epigallocatechin-3-gallate in preventing dermatitis in patients with breast cancer receiving postoperative radiotherapy.

2 Jun, 2022 | 10:34h | UTC

Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy: A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical Trial – JAMA Dermatology (free for a limited period)

Visual Abstract: Efficacy of Epigallocatechin-3-Gallate on Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy

 


RCT: Effect of supine vs. prone breast radiotherapy on acute toxic effects of the skin among women with large breast size.

27 May, 2022 | 11:51h | UTC

Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size: A Randomized Clinical Trial – JAMA Oncology (free for a limited period)

Editorial: Prone Whole-Breast Radiotherapy—Better Than Supine? (free for a limited period)

 

Commentary on Twitter

 


Position Paper: Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer.

26 May, 2022 | 10:42h | UTC

Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies – ESMO Open

 


RCT: The addition of Metformin to standard therapy did not improve outcomes in patients with breast cancer.

25 May, 2022 | 11:49h | UTC

Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Who Will Benefit From Metformin? – JAMA Oncology

News Release: Common diabetes drug not effective against early-stage breast cancer, landmark trial reveals – Lunenfeld-Tanenbaum Research Institute

 


Top 100 most-cited articles on enhanced recovery after surgery.

24 May, 2022 | 10:38h | UTC

Top 100 Most-Cited Articles on Enhanced Recovery After Surgery: A Bibliometric Analysis and Visualized Study – Frontiers in Surgery

See also: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines

 


Mammographic breast density, benign breast disease, and subsequent breast cancer risk in 3.9 million Korean women.

19 May, 2022 | 10:51h | UTC

Mammographic Breast Density, Benign Breast Disease, and Subsequent Breast Cancer Risk in 3.9 Million Korean Women – Radiology

News Release: Density, benign disease raise risk of breast cancer – Radiological Society of North America

 


Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy – A prospective interventional study.

19 May, 2022 | 10:15h | UTC

Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy – A prospective interventional study – The Breast

 


Nonrandomized Controlled Trial: Clinical impact of intraoperative margin assessment in breast-conserving surgery with a novel Pegulicianine Fluorescence–guided system.

18 May, 2022 | 10:28h | UTC

Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence–Guided System: A Nonrandomized Controlled Trial – JAMA Surgery

 

Commentary on Twitter

 


Retrospective Cohort Study: Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer.

9 May, 2022 | 01:40h | UTC

Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study – British Journal of Cancer

 

Commentary on Twitter

 


Recommendations for breast cancer screening in women with extremely dense breasts.

4 May, 2022 | 08:11h | UTC

Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI) – European Radiology

 


RCT: Digital breast tomosynthesis plus synthesized mammography versus digital screening mammography for the detection of invasive breast cancer.

1 May, 2022 | 23:14h | UTC

Digital breast tomosynthesis plus synthesised mammography versus digital screening mammography for the detection of invasive breast cancer (TOSYMA): a multicentre, open-label, randomised, controlled, superiority trial – The Lancet Oncology (link to abstract – $ for full-text)

Commentary: Breast Cancer Screening With Digital Breast Tomosynthesis Plus Synthesized Mammography vs Digital Mammography – The ASCO Post

 


Stay Updated in Your Specialty

No spam, just news.